Welcome to PsychU!

Foundations & Future Plans For Precision Medicine In The Treatment Of GAD

You must be logged-in to view this content.

Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses

You must be logged-in to view this content.

Log In

The Neurobiology Of Endocannabinoids

You must be logged-in to view this content.

The Neurobiology Of Opioids

You must be logged-in to view this content.

The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

Webinar Summary – Gender Differences In Depression

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, …

You must be logged-in to view this content.

Webinar Summary: Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members …

You must be logged-in to view this content.

Evolving Pharmacology Of Depression: Beyond The Monoamine Hypothesis

According to the World Health Organization, major depressive disorder (MDD) currently impacts 300 million individuals worldwide and is the leading …

You must be logged-in to view this content.

Webinar Summary – Evolving Psychopharmacology Of Depression: Beyond The Monoamine Hypothesis

You must be logged-in to view this content.

Neuromodulation Techniques: State Of The Science

Clinicians managing patients with behavioral health issues are presented with various diagnostic and treatment challenges, spanning the areas of neurobiology, …

You must be logged-in to view this content.

Webinar Summary – The Evolution Of Post-Traumatic Stress Disorder: Focus On Diagnostic, Evaluation, & Treatment Advances

You must be logged-in to view this content.

The Evolution Of Post-Traumatic Stress Disorder: Focus On Diagnostic, Evaluation, & Treatment Advances

During this webinar William Sauvé, MD, Regional Medical Director at Greenbrook TMS Neurohealth in Glen Allen, Virginia and Steven Szabo, …

You must be logged-in to view this content.

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, & Therapy

You must be logged-in to view this content.

Genetic Variation & The D2 Dopamine Receptor: Implications For The Treatment Of Neuropsychiatric Disease

You must be logged-in to view this content.

Schizophrenia: The Role Of Sleep & Circadian Rhythms In Regulating Dopamine & Psychosis

You must be logged-in to view this content.

Clinical Application Of Psychopharmacology Of Schizophrenia – John Miller, MD

This interview with John Miller, MD is part 3 of the 3-part module series on Schizophrenia, from the Psychopharmacology Collection.

You must be logged-in to view this content.

Pathophysiology & Evolving Theories In Schizophrenia

This presentation is part 2 in a series focusing on the psychopharmacology of schizophrenia. This presentation reviews regions of the …

You must be logged-in to view this content.

Webinar Summary – Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

You must be logged-in to view this content.

Advanced Receptor Psychopharmacology

This video is part 3 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This …

You must be logged-in to view this content.

Neurotransmitter Functioning In Major Depressive Disorder

This video is part 1 of a series on Major Depressive Disorder (MDD), from the Psychopharmacology Collection. This video introduces …

You must be logged-in to view this content.

Advanced Neurotransmitters & Neuroglia

This video is part 2 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This …

You must be logged-in to view this content.

Clinical Application Of Psychopharmacology Of Major Depressive Disorder – Chris Bojrab, MD

This interview with Chris Bojrab, MD, is part 3 of the 3-part module series on Major Depressive Disorder (MDD), from …

You must be logged-in to view this content.

Potential Role Of Neurotransmitters & Treatment Considerations In Bipolar Disorder

This video is part 1 of a series on Bipolar Disorder, from the Psychopharmacology Collection. This video briefly reviews the proposed …

You must be logged-in to view this content.

Pharmacologic Treatments In Major Depressive Disorder

This video is part 2 of a series on Major Depressive Disorder (MDD), from the Psychopharmacology Collection. This video provides …

You must be logged-in to view this content.

Depression, Serotonin & Tryptophan

You must be logged-in to view this content.

Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

While past decades saw a boom in the development of innovative new treatments in the field of psychiatry, the pace …

You must be logged-in to view this content.

Basics In Psychopharmacology

This video is part 1 of the 3-part series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. …

You must be logged-in to view this content.

The Role Of NMDA Receptors In The Pathophysiology & Treatment Of Mood Disorders

You must be logged-in to view this content.

The Evolving Psychopharmacology Of Major Depressive Disorder

During this recorded presentation, David Scheiderer, MD, provided a brief overview of the psychopharmacology of major depressive disorder. Key points …

You must be logged-in to view this content.

Perspectives In Schizophrenia: Proposed Disease Pathophysiology & Potential Treatment Implications

You must be logged-in to view this content.

The Importance Of Norepinephrine In Depression

You must be logged-in to view this content.

Webinar Summary – Understanding The Role Of Neurotransmitters In The Treatment Of Depression

You must be logged-in to view this content.

Understanding The Role Of Neurotransmitters In The Treatment Of Depression

Major depressive disorder (MDD) is common, affecting an estimated 16 million US adults each year. However, less than 40% of …

You must be logged-in to view this content.

Webinar Summary – The Evolving Psychopharmacology Of Major Depressive Disorder: Narrowing The Treatment Gap

You must be logged-in to view this content.

The Evolving Psychopharmacology Of Major Depressive Disorder: Narrowing The Treatment Gap

Depression is a widespread condition estimated to affect millions of adults in the United States alone. Despite the significant burden …

You must be logged-in to view this content.

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Agitation is frequently seen in patients with schizophrenia. When treating acute agitation in these patients, minimizing sedation should be a …

You must be logged-in to view this content.

Management Of Major Depressive Disorder (MDD): Breaking Through The Barriers

An estimated 1 in 10 US adults report depression, with major depressive disorder (MDD) as common as diabetes or coronary …

You must be logged-in to view this content.

Does Relapse In Schizophrenia Cause Neurodegeneration? A Simulcast Debate & Webinar To Explore The Evidence

There is a continuous debate in the mental health community around the progressive nature of schizophrenia as a disease: Is …

You must be logged-in to view this content.